v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net loss $ (3,464) $ (10,780) $ (9,839) $ (12,689) $ (14,244) $ (22,528)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         1,474 1,812  
Allowance for credit losses         (160) 83  
Inventory impairment           177  
Share-based compensation         2,365 3,258  
Non-cash interest expense         478 388  
Loss on extinguishment of debt         539    
Loss on disposal of property and equipment         369 43  
Changes in certain assets and liabilities:              
Accounts receivable, net         893 (2,479)  
Inventory         (1,289) (791)  
Net investments in sales-type leases         24 12  
Prepaid commission expense         1,268 613  
Prepaid expenses and other assets         (647) 3,356  
Accounts payable         1,572 (1,803)  
Accrued expenses         (3,386) (2,236)  
Other liabilities         (85) (320)  
Deferred revenue         400 (82)  
Net cash used in operating activities         (10,429) (20,497) $ (20,400)
Cash flows from investing activities:              
Purchases of property and equipment and capitalized software         (614) (471)  
Proceeds from the sale of property and equipment         25    
Net cash used in investing activities         (589) (471)  
Cash flows from financing activities:              
Payments of debt issuance costs         (55)    
Repayment of deferred and contingent consideration         (250)    
Repayment of long-term debt         (5,000)    
Payment for debt extinguishment costs         (250)    
Distribution to non-controlling interest         (192)    
Proceeds from exercises of stock options           9  
Net cash provided by financing activities         1,831 18,978  
Net decrease in Cash, Cash equivalents and Restricted cash         (9,187) (1,990)  
Cash and cash equivalents and restricted cash and cash equivalents, beginning of period   $ 34,134   $ 19,459 34,134 19,459 19,459
Cash and cash equivalents and restricted cash and cash equivalents, end of period 24,947   17,469   24,947 17,469 34,134
Reconciliation of cash and cash equivalents and restricted cash and cash equivalents to the consolidated balance sheet:              
Cash and cash equivalents 19,197   10,969   19,197 10,969 28,134
Restricted cash and cash equivalents 5,750   6,500   5,750 6,500 6,000
Total cash and cash equivalents and restricted cash and cash equivalents 24,947   $ 17,469   24,947 17,469 $ 34,134
Supplemental disclosure of cash flow information:              
Cash paid for interest         3,918 3,488  
Transfer of inventory to property and equipment         114 36  
Supplemental disclosure of non-cash investing and financing activities:              
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses         103 6  
Secondary public offering              
Cash flows from financing activities:              
Proceeds from the issuance of common stock           20,700  
Payments of common stock offering issuance costs           $ (1,731)  
ATM Program              
Cash flows from financing activities:              
Proceeds from the issuance of common stock $ 8,000       7,954    
Payments of common stock offering issuance costs         $ (376)